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The replicase of mouse hepatitis virus strain JHM (MHV-JHM) is encoded by two overlapping open reading frames, ORF1a
and ORF1b, which are translated to produce a 750-kDa precursor polyprotein. The polyprotein is proposed to be processed
by viral proteinases to generate the functional replicase complex. To date, only the MHV-JHM amino-terminal proteins p28
and p72, which is processed to p65, have been identified. To further elucidate the biogenesis of the MHV-JHM replicase, we
cloned and expressed five regions of ORF1a in bacteria and prepared rabbit antisera to each region. Using the immune sera
to immunoprecipitate radiolabeled proteins from MHV-JHM infected cells, we determined that the MHV-JHM ORF1a is initially
processed to generate p28, p72, p250, and p150. Pulse–chase analysis revealed that these intermediates are further
processed to generate p65, p210, p40, p27, the MHV 3C-like proteinase, and p15. A putative replicase complex consisting of
p250, p210, p40, p150, and a large protein (.300 kDa) coprecipitate from infected cells disrupted with NP-40, indicating that
these proteins are closely associated even after initial proteolytic processing. Immunofluorescence studies revealed
punctate labeling of ORF1a proteins in the perinuclear region of infected cells, consistent with a membrane-association of
the replicase complex. Furthermore, in vitro transcription/translation studies of the MHV-JHM 3Cpro and flanking hydro-
phobic domains confirm that 3C protease activity is significantly enhanced in the presence of canine microsomal mem-
branes. Overall, our results demonstrate that the MHV-JHM ORF1a polyprotein: (1) is processed into more than 10 protein
intermediates and products, (2) requires membranes for efficient biogenesis, and (3) is detected in discrete membranous
regions in the cytoplasm of infected cells. © 1998 Academic Press
INTRODUCTION
Mouse hepatitis virus strain JHM (MHV-JHM) is a
member of the positive strand RNA virus family Corona-
viridae, in the new order Nidovirales (Cavanagh, 1997; de
Vries et al., 1997). Nido, Latin for ‘‘nest,’’ was chosen for
this order since the two virus families in the order, the
Coronaviridae and Arteriviridae, synthesize a 39-nested
set of mRNAs. Furthermore, the nested set of mRNAs is
generated by an unusual discontinuous transcription
process in which a short leader RNA sequence and the
body sequence of the mRNA are joined (Baric et al., 1983;
Lai et al., 1994; Spaan et al., 1983; van der Most and
Spaan, 1995). The mechanism by which this discontinu-
ous transcription occurs to generate the nested set of
mRNAs is controversial (Jeong and Makino, 1994;
Sawicki and Sawicki, 1990; Sethna et al., 1989; van Marle
et al., 1995; Zhang and Lai, 1995). However, it is clear that
the enzyme that mediates discontinuous transcription is
the viral RNA-dependent RNA polymerase, or replicase.
By understanding how this replicase is generated and
functions throughout the infection cycle, we may gain
insight regarding how it mediates the unusual mecha-
nism of discontinuous RNA synthesis.
The MHV-JHM replicase is encoded at the 59-end of
the positive strand RNA genome in a region designated
gene 1. Gene 1 encompasses 21.7 kb of the almost 32-kb
viral genome and contains two overlapping open reading
frames: ORF1a (13.6 kb) and ORF1b (8.1 kb) (Lee et al.,
1991; Pachuk et al., 1989). These two open reading
frames are joined by a 21 ribosomal frameshift that
occurs during translation of gene 1, leading to the gen-
eration of a 750-kDa replicase polyprotein (Brierley et al.,
1987; Lee et al., 1991). This large polyprotein is thought to
be processed by viral proteinases to generate the ma-
ture, functional replicase complex.
Within gene 1 of MHV there are three predicted pro-
teinase domains, two of which are papain-like cysteine
proteinase domains (PCP-1 and PCP-2) and a third which
is poliovirus 3C-like (3Cpro) (Gorbalenya et al., 1989; Lee
et al., 1991). To date, only PCP-1 and 3Cpro of MHV have
been demonstrated to have activity (Baker et al., 1989,
1993; Bonilla et al., 1997; Lu et al., 1995). The first protein
to be processed from the replicase polyprotein, p28, is
cleaved from the amino-terminus of the ORF1a polypro-
tein precursor by the PCP-1 proteinase (Baker et al.,
1989; Denison and Perlman, 1987). This is followed by
processing of the adjacent 72-kDa protein and its cleav-
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age to a 65-kDa protein in MHV-JHM (Gao et al., 1996).
For MHV-A59, p65 has been detected, followed by a
290-kDa protein which is processed into p240 and p50
(Denison et al., 1992, 1995). Two proteins of 27 and 29
kDa, representing the 3Cpro, have also been detected
from MHV-A59-infected cells, but no precursor to this
protein was detected (Lu et al., 1996; Pin˜o´n et al., 1997).
To determine the biogenesis of the MHV-JHM replicase,
we sought to identify ORF1a precursors and products
from virus-infected cells. Elucidation of the steps in the
biogenesis of the coronavirus polymerase from its
polyprotein precursor to its functional subunits will aid
our understanding of coronavirus transcription, replica-
tion, and RNA recombination and may provide valuable
insight into targets for anti-viral drug design.
For this study, we prepared rabbit antisera against five
regions within MHV-JHM ORF1a and determined that at
least 10 intermediates and products are generated by
proteolytic processing of the precursor replicase
polyprotein. Using pulse–chase analyses, we deter-
mined precursor–product relationships between several
of these proteins. In addition, we provide immunofluo-
rescence and in vitro processing data to support the
hypothesis that the MHV-JHM replicase is a cytoplasmic,
membrane-associated enzyme complex.
RESULTS
Identification of MHV-JHM polymerase gene products
To elucidate the biogenesis of the coronavirus RNA-
dependent RNA polymerase, we generated polyclonal
antisera against five regions of MHV-JHM ORF1a. To
prepare each antigen of interest, domains within gene 1
were RT-PCR amplified from total RNA of MHV-JHM-
TABLE 1
Primers Used for PCR Amplification of MHV-JHM ORF1a Domains
Primer name Oligonucleotide sequence (59 to 39)a
Nucleotides
of ORF1ab Polarity Domain generated
FP22 TATCTAGAAGGCTGTTGTAAGC 2563–2576 1 D3
FP23 TGAAGCTTCAGTTGCCTTGACC 3313–3326 2
FP1 TATCTAGACGTGTTTTTCTATGGAGACG 3847–3866 1 D5
B11 ACCACCGGTAGACTCATAGC 4374–4393 2
FP28 TATCTAGATACGTATAACAAGCAGGAGG 8671–8690 1 D10
FP29 TGAAGCTTTGCAGTAGGTCATGGAGCGC 9376–9395 2
FP2 TATCTAGAAGTGAAGATGGTGTCC 10231–10246 1 D12
FP3 TGAAGCTTTATGGCTGCTACGC 10612–10625 2
FP12 ATTCTAGACTCTGCAAATAGGC 12811–12824 1 D15
FP13 TGAAGCTTTGACTGAAACTGGG 13584–13597 2
B151 GCTCTAGAATAATGGCCTTTGGTGACTACAC 9650–9666 1 3Cpro
B158 ATGAATTCTCATGCAATGTGCAAGTGC 12049–12064 2
B153c TTGGATCCAGAGGTTCTGTAGGG 10649–10669 1 mut3Cpro
B158 ATGAATTCTCATGCAATGTGCAAGTGC 12049–12064 2
a Underlined nucleotides refer to sequences added for cloning purposes.
b Nucleotides numbered according to Lee et al. (1991) as modified by Bonilla et al. (1994).
c Nucleotides in bold indicate base mismatches incorporated into the primer sequence which result in a change in the coding sequence from
cysteine to arginine. This amplified product was ligated into the BamHI–EcoRI site of pET-3Cpro as described under Materials and Methods.
TABLE 2
Antisera Generated Against GST/MHV-JHM-ORF1a Fusion Proteins
Antiserum
Number of amino acids
in ORF1a antigen
Primers used for
PCR
amplificationa
Amino acid position in
the ORF1a proteinb
ORF1a products detected
by immunoprecipitation
aD3 254 FP22–FP23 784–1037 p250, p210, p72, p65c
aD5 154 FP1–B11 1212–1365 p250, p210c
aD10 241 FP28–FP29 2820–3060 p250, p210c
aD12 131 FP2–FP3 3340–3470 p150, p27
aD15 262 FP12–FP13 4200–4461 p150, p15
a See Table 1 for details regarding each primer.
b Amino acids numbered according to Lee et al. (1991) as modified by Bonilla et al. (1994).
c p40 detected using lysis method B with aD3, aD5, and aD10 antisera (see Fig. 4).
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infected cells (see Tables 1 and 2), cloned in frame with
glutathione S-transferase (GST) in the bacterial expres-
sion vector pGEX-KG, and expressed as described under
Materials and Methods. Affinity-column-purified GST-fu-
sion proteins were used for rabbit immunizations, and
sera were collected 10–14 days following each injection.
Antibody titer was determined by ELISA assay to GST
antigen alone and GST-ORF1a fusion proteins. Final
bleed antisera had titers greater than 80,000 against
GST-ORF1a fusion proteins.
To identify MHV-JHM ORF1a products, immunoprecipi-
tations from MHV-JHM-infected DBT cell lysates were
performed using the D3, D5, and D10 antisera. The fu-
sion proteins used to generate these antisera cover
amino acids 784–1037, 1212–1365 and 2820–3060, re-
spectively (Table 2). Immunoprecipitations with these
antisera led to the identification of two high-molecular-
weight proteins with apparent migrations of 250 and 210
kDa (Figs. 1 A–1C, lane 4). Longer exposure of the
anti-D3 immunoprecipitation revealed proteins of 72 and
65 kDa (Fig. 1A, lane 4), confirming our earlier report of
these products (Gao et al., 1996). In addition, we noted
proteins with apparent migrations of 180 and 50 kDa
which are nonspecifically recognized by all preimmune
and immune sera from infected cell lysates. These bands
likely reflect some nonspecific immunoprecipitation of
the highly abundant spike (180 kDa) and nucleocapsid
(50 kDa) proteins produced during viral replication, as
has been previously reported (Denison et al., 1992, 1995).
Taken together, the immunoprecipitation results suggest
that p250 and p210 may be co-amino terminal (as both
are precipitated by anti-D3, which extends only 14.2 kDa
into the predicted p250 region), and both proteins extend
to at least aa 2820 (as both are precipitated by anti-D10).
To study the synthesis and processing of p250 and
p210 in vivo, pulse–chase analyses were performed
(Figs. 1D–1F). MHV-JHM infected cells were pulsed with
[35S]methionine for 30 min, washed with PBS, chased
with unlabeled media, and lysed as described under
Materials and Methods. Immunoprecipitation of these
lysates with anti-D3, anti-D5, and anti-D10 sera revealed
a gradual decline in the intensity of p250 and concomi-
tant increase in the intensity of p210, suggesting that
p250 and p210 have a precursor–product relationship.
We also expected to find a protein of approximately 40
kDa which would represent the remaining cleavage
product of p250. However, we have been unable to de-
tect p40 using this method. Therefore, we cannot yet
definitively conclude whether p210 is co-amino- or co-
carboxy-terminal with p250. Amino-terminal sequencing
of p250 and p210 will be required to determine if they are
truly co-amino-terminal, and at which precise amino acid
they begin. To date, we have been unable to purify
sufficient quantities of these proteins for amino-terminal
sequencing studies.
The detection of some unprocessed p250 even 120
min into the chase (Figs. 1D–1F, lane 6) suggests that the
cleavage of p250 to p210 likely occurs slowly and post-
translationally. This is in contrast to the rapid cleavage of
the amino-terminal product of the polymerase polypro-
tein, p28, which likely occurs cotranslationally and in cis
(Denison and Perlman, 1987; Gao et al., 1996), although it
has been recently shown that the cleavage can also be
mediated in trans in vitro using an internal deletion
construct of the 59 end of the MHV-A59 ORF1a (Bonilla et
al., 1997). The differences in the rates of processing may
have important implications on replicase assembly and
function (see Discussion).
Comparison of MHV-JHM and MHV-A59 ORF1a gene
products
Two high molecular mass proteins, p290 and p240,
have previously been reported as ORF1a cleavage
products of MHV-A59 (Denison et al., 1992, 1995). To
determine if the MHV-JHM ORF1a processing is dis-
tinct from MHV-A59, we analyzed radiolabeled A59
and JHM lysates by immunoprecipitation with anti-D3
serum and SDS–PAGE (Fig. 2A). As seen in lanes 5 and
6, the high molecular mass proteins from both virus
strains migrate identically under denaturing condi-
tions in a 5–15% gradient SDS–polyacrylamide gel.
According to our molecular mass determinations (see
Materials and Methods), these proteins migrate with
apparent masses of 250 and 210 kDa. Furthermore,
these molecular mass estimates are consistent with
the expected molecular mass calculated for the region
bounded by p72 and the downstream protein p150
described below (see Fig. 7 and Table 3). Interestingly,
the p72 protein appears to be unique to the MHV-JHM
strain. Alignment of amino acids surrounding the p65
and p72 cleavage sites indicates that the p65 cleavage
FIG. 1. Detection of MHV-JHM ORF1a gene products by immunoprecipitation with specific antisera. (A, B, and C) Mock-infected and MHV-JHM
infected DBT cells were labeled with [35S]methionine from 6.0 to 7.5 h p.i. and lysed in buffer A, as described under Materials and Methods. Viral
proteins were immunoprecipitated from lysates of mock-infected (lanes 1 and 3) and JHM-infected (lanes 2 and 4) cells using preimmune sera (lanes
1 and 2) and the indicated immune sera (lanes 3 and 4). Proteins p250, p210, p72, and p65 found only in infected cell lysates with immune sera are
indicated by arrows. (D, E, and F) Pulse–chase analyses indicating precursor–product relationships between proteins. Mock-infected and JHM-
infected cells were labeled with [35S]methionine from 6.0 to 6.5 h p.i., washed with normal media, and then chased for the indicated periods of time
in media containing excess cold methionine before lysis in buffer A and immunoprecipitation as described above. U, uninfected cell lysates; I, infected
cell lysates. All samples were analyzed by electrophoresis in 5–15% gradient SDS–PAGE gels and visualized by fluorography. Molecular mass markers
are labeled in kilodaltons on the left of each gel. Exposure lengths are indicated below each gel.
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site is identical in the two strains, whereas there is
one potentially significant difference at the P1 position
of the predicted p72 cleavage site (a Gly to Asp sub-
stitution; see Fig. 2B). This substitution may prevent
recognition of this cleavage site in the A59 ORF1a
polyprotein and therefore explain the absence of the
p72 product in A59-infected cells.
Identification of MHV-JHM 3Cpro and its precursor
polyprotein
All coronavirus genomes studied to date encode a po-
liovirus 3C-like proteinase domain (3Cpro) (Bonilla et al.,
1994; Boursnell et al., 1987; Eleouet et al., 1995; Gorbalenya
et al., 1989; Herold et al., 1993; Lee et al., 1991). For MHV-
TABLE 3
Comparison of Observed and Predicted Molecular Masses for MHV-JHM ORF1a Products
Observed molecular mass of
ORF1a proteins (kDa)
Predicted amino acids
in the ORF1a
polyproteina
Molecular mass of predicted
regions (kDa)
28 Met (1)–Gly (247)b 27.5
72 Val (248)–Gly (904) 73.0
65 Val (248)–Ala (832)c 65.0
—d Gly (833)–Gly (904) 7.9
250 Val (905)–Gly(3126) 246.7
150 Ala (3127)–Val(4474) 150.5
27 Ser(3337)e–Glu(3639) 33.2
500-kDa ORF1a polyproteinf
(p28 1 p72 1 p250 1 p150)
Met (1)–Val(4474) 497.6
a Amino acids numbered according to Lee et al. (1991) as modified by Bonilla et al. (1994).
b p28 cleavage site as determined by Dong and Baker (1994) and Hughes et al. (1995).
c p65 cleavage site as determined by Bonilla et al. (1997).
d Protein product predicted but not observed.
e p27 amino-terminal cleavage site as determined by Lu and Denison (1997).
f The predicted uncleaved product is not observed because it is cleaved cotranslationally.
FIG. 2. Direct comparison of high molecular mass ORF1a proteins from MHV strains JHM and A59. (A) Immunoprecipitations were performed as
described in the legend to Fig. 1, using both preimmune and anti-D3 immune sera. The top half of the Fig. shows a short (16.5 h) exposure, and the
bottom half a longer (168 h) exposure of the same gel. U, uninfected cell lysates; J, JHM-infected cell lysates; A, A59-infected cell lysates. Proteins
p250, p210, and p65 are detected in JHM and A59 lysates (lanes 5 and 6), whereas p72 is detected only in JHM lysates (lane 5). Molecular mass
markers are indicated on the left of the gel, and exposure lengths are indicated below. (B) Comparison of JHM and A59 p65 and putative p72 cleavage
sites. Amino acids flanking the cleavage sites are depicted in bold; dots indicate amino acid identity between virus strains.
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A59, this domain spans amino acids 3334–3636 (corre-
sponding to amino acids 3337–3639 of MHV-JHM). For the
coronaviruses MHV-A59, avian infectious bronchitis virus
(IBV) and human coronavirus (HCV-229E), this domain has
been shown to have protease activity when translated in
vitro, purified from virus-infected cells, or expressed in bac-
teria and purified (Lu et al., 1995, 1996; Seybert et al., 1997;
Tibbles et al., 1996; Ziebuhr et al., 1995). The catalytic
cysteine and histidine residues of the MHV-A59 and IBV
proteases have been identified (Liu and Brown, 1995; Lu
and Denison, 1997; Lu et al., 1995), and the 3Cpro domain
was detected by immunoprecipitation from MHV-A59-in-
fected cell lysates in two different reports as a 27- or 29-kDa
protein (Lu et al., 1996; Pin˜o´n et al., 1997). To identify the
MHV-JHM 3Cpro, we prepared the fusion protein antiserum
D12. The D12 domain is located within the 3C protease,
specifically covering the catalytic histidine residue but not
the cysteine residue (amino acids 3340–3470).
Immunoprecipitation with anti-D12 serum from MHV-
JHM-infected cell lysates identified proteins of 27 and
150 kDa on 5–15% gradient SDS–PAGE gels (Fig. 3A, lane
4). Pulse–chase analysis with anti-D12 serum suggests a
precursor and product relationship between p150 and
p27, as reflected by the appearance of p27 30 min into
the chase, and the concomitant decrease in intensity of
p150 (Fig. 3C). This result is consistent with proteolytic
cleavages mediated by 3Cpro occurring at Gln/Ser cleav-
age sites upstream and downstream of the 3Cpro cata-
lytic center, as has been reported for MHV-A59 (Lu et al.,
1996). The detection of p150 is the first report of a
precursor to 3Cpro. We propose that the p150 extends
from a putative cleavage site upstream of the hydropho-
bic domain termed MP1 (Gorbalenya et al., 1989; Lee et
al., 1991) to the end of ORF1a (Val 4474). The predicted
molecular weight for this region is 150.5 kDa, similar to
the apparent molecular weight of 150 kDa on SDS–PAGE
gels (Table 3).
Immunoprecipitations of JHM-infected cell lysates with
antiserum D15, directed against amino acids 4200–4461
near the carboxy-terminal region of ORF1a further support
this hypothesis. The D15 antiserum immunoprecipitates a
150-kDa protein that decays with kinetics identical to those
seen in the anti-D12 pulse–chase (Figs. 3B and 3D). To
detect lower-molecular-weight cleavage products of p150,
we analyzed the products by 15% SDS–PAGE (Fig. 3E). After
prolonged exposure, we detected a product of 15 kDa
which accumulates during the chase period. The p15 likely
represents the carboxy-terminal or penultimate cleavage
product of MHV-JHM ORF1a.
Effect of lysis conditions on detection of MHV-JHM
ORF1a gene products
While working to optimize the conditions for immuno-
precipitation of MHV-JHM ORF1a gene products, we
found that the conditions used to prepare the cell lysates
were critical for the detection of all MHV-JHM ORF1a
products. We routinely use highly denatured total cell
lysates (prepared using lysis buffer A as described under
Materials and Methods) for immunoprecipitations. As
shown above (Fig. 1), these conditions facilitate specific
detection of MHV-JHM ORF1a gene products. Interest-
ingly, when cell lysates were prepared using NP-40 lysis
followed by isolation of postnuclear supernatants (lysis
buffer B, see Materials and Methods), we detected co-
precipitation of viral proteins, indicating that these pro-
teins likely reside in the cell as a complex. Under these
conditions, all five antisera described above precipitate
viral proteins of .300 kDa, p250, p210, and p150 (Fig. 4).
A protein of approximately 40 kDa is also detected using
the anti-D3, anti-D5, and anti-D10 sera. In pulse–chase
analyses of NP-40 lysates with these same three anti-
sera, p40 is seen to accumulate during the chase con-
comitant with the increase in p210 and decrease in p250
intensities (data not shown). This viral p40 likely repre-
sents the additional cleavage product generated when
p250 is cleaved to generate p210. Since neither the
anti-D3 nor anti-D10 serum specifically immunoprecipi-
tates this product, it is unclear if p40 represents the
amino- or carboxy-terminal cleavage product of p250.
The large (.300 kDa) protein likely represents an
ORF1a/ORF1b polyprotein generated by ribosomal
frameshifting during translation. In addition to the high-
molecular-weight proteins, some specific products are
also detected: p65 using anti-D3 (Fig. 4, lane 2), p27
using anti-D12 (lane 8), and p15 using anti-D15 (lane 10).
The specific precipitation of the lower molecular-weight
proteins demonstrates the specificity of the antisera. The
coprecipitation of the high molecular weight proteins
under these conditions is consistent with the hypothesis
that the MHV polymerase exists as a complex of ORF1a/
ORF1b cleavage products in vivo.
Detection of MHV-JHM ORF1a proteins by
immunofluorescence
To determine the intracellular localization of MHV-JHM
ORF1a proteins, immunofluorescence studies were per-
formed. DBT cells were infected with MHV-JHM, fixed
with formaldehyde at 5.5–6.0 h after infection, and incu-
bated with specific antisera as described under Materi-
als and Methods. MHV ORF1a products were detected
using anti-D3 and anti-D12 antisera (Fig. 5). Both antisera
revealed a similar, and somewhat polar, punctate stain-
ing pattern in the perinuclear region of infected cells.
This pattern is consistent with MHV replicase associa-
tion with discrete vesicular structures in the cells. Al-
though not all gene 1 cleavage products are predicted to
contain hydrophobic domains, it is possible that strong
protein–protein interactions hold the subunits together in
a membrane-associated complex. The MHV ORF1a lo-
calization we see is similar to the pattern of localization
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reported for ORF1b proteins in equine arteritis virus
(EAV)-infected cells (van Dinten et al., 1996). Further
studies will be required to determine the precise subcel-
lular localization site of the MHV replicase complex.
Effect of membranes on MHV-JHM 3Cpro activity
In the case of the IBV 3C-like proteinase, canine mi-
crosomal membranes (CMMs) have been shown to be
FIG. 3. Identification of the precursor and processed forms of the C-terminal region of ORF1a by immunoprecipitation with specific antisera.
Immunoprecipitations and pulse–chase analyses were performed as described in the legend to Fig. 1, using anti-D12 (A and C) and anti-D15 (B, D,
and E) antisera. Samples were analyzed by electrophoresis in 5–15% gradient SDS–PAGE (A–D) or 15% (E) gels and visualized by fluorography. U,
uninfected cell lysates; I, infected cell lysates; pre, immunoprecipitations using preimmune sera; remaining lanes immunoprecipitated with the
indicated immune sera. Proteins p150, p27 (3Cpro), and p15 are indicated by the arrows. Molecular mass markers are indicated on the left, and
exposure lengths are indicated below each gel.
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necessary for in vitro 3Cpro protease activity (Tibbles et
al., 1996). However, for MHV-A59 it has been demon-
strated that 3Cpro (p27) does not strictly require mem-
branes for in vitro trans-cleavage activity (Lu et al., 1996),
but that it does require membranes for efficient activity if
major portions of the flanking hydrophobic domains are
present in the expression constructs (Pin˜o´n et al., 1997).
To investigate the activity of the MHV-JHM 3Cpro, the
predicted protease domain along with the full-length
flanking hydrophobic domains (MP1 and MP2, mem-
brane proteins 1 and 2) were cloned into the in vitro
expression vector pET-11d under T7 promoter control
and tested for protease activity in the presence and
absence of membranes. A mutant 3Cpro construct was
generated by polymerase chain reaction (PCR) mutagen-
esis, resulting in a substitution of the catalytic cysteine
residue with an arginine residue (Table 1). Both wild type
and mutant 3Cpro constructs were cotranscribed/trans-
lated in vitro with [35S]methionine in the absence and
presence of CMMs, and equal TCA-precipitable counts
of each reaction were analyzed by SDS–PAGE and au-
toradiography (Fig. 6). Comparison of lanes 1 and 2 from
this experiment indicates that the p27 cleavage product
(3Cpro) is generated more efficiently from the 91 kDa
translation product in the presence of CMMs (Fig. 6, lane
2). This may be due to an effect of membranes on the
conformation of the proteinase itself or to an alteration in
accessibility of the cleavage sites. Longer exposures of
the gel in Fig. 6 show small quantities of p27 generated
in the absence of membranes, in lane 1 (data not shown).
As expected, pET-mut3Cpro does not generate p27 in the
absence or presence of membranes (lanes 3 and 4).
These results are consistent with the observations of
Pin˜o´n et al. (1997) in that 3C processing events specifi-
cally leading to the release of p27 in vitro can occur in
the absence of exogenously added membranes, but that
they are greatly enhanced in the presence of CMMs.
Finally, these data support the hypothesis that 3Cpro
likely needs to be associated with intracellular mem-
branes for efficient activity during virus infection.
DISCUSSION
Here we report the identification of six MHV-JHM gene
1 products, p250, p210, p40, p150, p27, and p15, which,
together with the previously described products p28,
p72, and p65, span the entire 4474 amino acids encoded
by ORF1a (Table 3). Based on apparent molecular
masses of proteins identified by immunoprecipitation
using antisera generated to ORF1a fusion proteins, as
well as the known location of each fusion protein
epitope, we deduced that the ORF1a polyprotein is ini-
tially cleaved to generate four products, p28, p72, p250,
and p150 (Fig. 7). P28, the amino-terminal cleavage prod-
uct, is rapidly cleaved and is stable for at least 90 min
after processing (Baker et al., 1989; Denison and Perl-
man, 1986; Gao et al., 1996). P72, p250, and p150 repre-
sent intermediates in the proteolytic processing of
FIG. 4. Immunoprecipitation of MHV-JHM ORF1a gene products from the postnuclear supernatant of infected cells. Mock-infected and MHV-JHM
infected DBT cells were labeled with [35S]methionine from 6.0 to 8.0 h p.i., lysed in buffer B as described under Materials and Methods, and the
postnuclear supernatants were immunoprecipitated with the indicated immune sera, electrophoresed on 5–15% gradient SDS–PAGE gels, and
visualized by fluorography. U, uninfected cell lysates; I, infected cell lysates. Using this technique, proteins .300 kDa, p250, p210, and p150 are
detected with all sera from infected cell lysates. In contrast, p40 is detected with anti-D3, anti-D5, and anti-D10 sera (lanes 2, 4, and 6), p65 is detected
only with anti-D3 serum (lane 2), p27 is detected only with anti-D12 serum (lane 8), and p15 is detected only with anti-D15 serum (lane 10). Molecular
mass markers are indicated on the left, and exposure lengths are indicated below each gel.
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ORF1a. P72 is processed to p65 (Gao et al., 1996, and
Fig. 1D). P250 is processed to p210 and p40, with p40
likely representing the carboxy-terminal cleavage prod-
uct of p250 (Figs. 1 and 4). P150, which represents the
carboxy-terminal region of ORF1a, is processed to p27,
the MHV-JHM 3C-like proteinase, and p15 (Fig. 3). P150
is likely processed into several additional products as
well.
Direct comparisons of MHV-JHM and A59 ORF1a gene
products identified to date suggest that there may be one
or more processing events unique to each strain. To
determine if the high molecular mass JHM ORF1a prod-
ucts p250 and p210 identified here are distinct from
previously described high molecular mass A59 products
p290 and p240 (Denison et al., 1992, 1995), we directly
compared anti-D3 immunoprecipitations from radiola-
beled JHM and A59 lysates (Fig. 2). Identical rates of
migration by SDS–PAGE suggest that the two proteins,
which under these conditions migrate with apparent mo-
lecular masses of 250 and 210 kDa, likely represent
comparable regions of ORF1a from both strains. A pro-
cessing event which is unique is the generation of p72 in
the MHV-JHM strain. Immunoprecipitation of JHM and
A59 lysates with anti-D3 (Fig. 2A) and anti-647 sera (H. Q.
Gao and S. C. Baker, unpublished observations) demon-
strated that the p72 protein is unique to the JHM strain.
This is likely due to the presence of a putative PCP-1
cleavage site in the JHM strain that is not conserved in
the A59 strain (Fig. 2B).
We show that the MHV-JHM ORF1a polyprotein is
cleaved into at least 10 intermediates and protein prod-
FIG. 6. Effect of membranes on 3Cpro proteolytic activity. In vitro
cotranscription/translation was performed in rabbit reticulocyte lysates
using the TNT expression system (as described under Materials and
Methods), in the absence (2) and presence (1) of canine microsomal
membranes (CMMs), as indicated for each lane. Equal TCA precipita-
ble counts were analyzed by 12.5% SDS–PAGE and fluorography. The
uncleaved 91-kDa precursor and 27-kDa product (likely representing aa
3337–3639 of the 3Cpro domain) are indicated. Molecular mass mark-
ers are shown on the left of the gel, and exposure length is indicated
below.
FIG. 7. Schematic representation of MHV-JHM ORF1a processing products. The 4474-amino-acid-long ORF1a polyprotein is cleaved to generate a
series of intermediates and products depicted here, reflecting results described in this paper. Fusion protein domains used to generate antisera and
detect cleavage products are depicted on the amino acid scale at the top. MHV-JHM ORF1a cleavage products are depicted with the observed
molecular mass of each protein shown inside each box. Viral proteins labeled 6.0–6.5 h p.i. cleave rapidly to generate p28 and the downstream
intermediates p72, p250, and p150. Intermediates are processed at varying rates to generate products p65, p210, p40, p27, and p15, all of which remain
stable during a 180-min chase period. The three previously defined cleavage sites at the carboxy-terminus of p28, the carboxy-terminus of p65, and
the amino-terminus of 3Cpro (p27) are shown. The G/V and A/G cleavage events are mediated by PCP-1, and the Q/S cleavage is mediated by 3Cpro.
The exact amino- and carboxy-termini of all other proteins have not yet been determined, as depicted by the dotted lines. The location of the internal
cleavage of p250 which results in the generation of p210 and p40 has not been definitively determined. Question marks indicate putative products
that remain to be identified.
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ucts, and clearly more products await identification. The
proteolytic pathway used to generate these protein prod-
ucts is being actively investigated. To date, we know that
the first papain-like cysteine proteinase (PCP-1) cleaves
at G/V and A/G sites to generate p28 and p65, respec-
tively (Bonilla et al., 1997; Dong and Baker, 1994; Hughes
et al., 1995). Based on the size estimates of the cleavage
products identified here and an analysis of potential
cleavage sites, we speculate that PCP-1 (or potentially
the PCP-2 domain located downstream of PCP-1) is re-
sponsible for cleavage of p72 and p250. Putative cleav-
age sites and size estimates of the resulting protein
products are listed in Table 3. The relative positions of
p210 and p40 are currently unclear since neither anti-D3
nor anti-D10 serum specifically immunoprecipitates p40.
Because the D3 antigen encompasses only the amino
terminal 14.2 kDa of p250 and the anti-D3 antiserum
detects both p250 and p210, it is likely that p250 and p210
are co-amino-terminal. However, if p250 and p210 are
co-amino-terminal, the D10 antiserum should encom-
pass regions of both p210 and p40. It is currently unclear
why we are unable to specifically precipitate p40 with
any antiserum.
The proteolytic processing of the Nidovirus poly-
merases appears to be quite complex, requiring multiple
proteinases and generating multiple intermediates. For
the best studied Nidovirus, EAV, the 1727-aa (187-kDa)
ORF1a polyprotein is cleaved into at least eight protein
products (nsp1–8) by three distinct viral proteinases.
Furthermore, alternative (and likely mutually exclusive)
major and minor processing pathways for the EAV
ORF1a polyprotein have been proposed (Wassenaar et
al., 1997). In addition, provisional mapping of the EAV
ORF1b polyprotein suggests that there are at least four
ultimate ORF1b cleavage products. However, since pro-
teolytic processing of the EAV ORF1b polyprotein occurs
quite slowly, a number of intermediates are also present
in EAV-infected cells (van Dinten et al., 1996). These
findings illustrate the complexity of Nidovirus replicase
complexes.
It is likely that some of the intermediates generated
during processing of the MHV gene 1 polyprotein medi-
ate functions distinct from those of the final processed
products. The cleavage of p250 to p210 and p40 occurs
relatively slowly in infected cells, with p250 still detect-
able 120 min after pulse labeling (Fig. 1). It is possible
that MHV replicase complexes consisting of differentially
processed ORF1a products are present in infected cells
and exert distinct functions on viral RNA synthesis. In the
Sindbis virus system it has been shown that replication
of the viral RNA to negative sense and back to positive
sense transcripts is regulated by differential processing
of a nonstructural protein precursor P123 (de Groot et al.,
1990; Lemm and Rice, 1993; Shirako and Strauss, 1994).
Early after Sindbis virus infection, P123 together with
nsP4 forms the negative strand replication complex. In
contrast, late in infection after the viral nsP2 proteinase
has accumulated to significant levels, fully processed
nsP1, nsP2, nsP3, and nsP4 form the positive strand
replication complex and shift viral RNA synthesis from
the production of negative strand templates to the pro-
duction of genome-sense transcripts. Similar to Sindbis
virus, the coronavirus replicase contains numerous
cleavage sites and several proteinase domains respon-
sible for processing the large replicase polyprotein. Ac-
cumulation of the viral PCP-1 and 3Cpro proteinases
during the course of infection very likely alters the kinet-
ics of trans-cleavage events and the stability of the p72,
p250, and p150 processing intermediates which may
play distinct regulatory roles in coronavirus genome rep-
lication.
Membrane association of many positive-strand RNA
virus replication complexes has been described in the
literature (Bienz et al., 1994; Chambers et al., 1990; Fros-
hauer et al., 1988; van Dinten et al., 1996). Due to the
presence of predicted hydrophobic stretches within the
MHV gene 1 polyprotein (Gorbalenya et al., 1989; Lee et
al., 1991), it is thought that some of the mature gene 1
products may be transmembrane proteins which serve to
anchor the viral replicase complex to membranes via
protein–protein interactions. In this report, we demon-
strate that the MHV-JHM ORF1a proteolytic products are
present as a complex in virus-infected cells. When in-
fected cells are disrupted by mild detergent (0.5% NP-40),
protein complexes are precipitated with ORF1a antisera
(Fig. 4). These complexes consist of: a high-molecular-
weight protein (.300 kDa) which we speculate extends
from ORF1a into ORF1b by ribosomal frameshifting dur-
ing translation; p250, p210, and p40 which represent the
central domain of ORF1a and include the two papain-like
cysteine proteinases, PCP-1 and PCP-2; and p150, which
represents the carboxy-terminal portion of ORF1a and
includes the 3C-like proteinase. Intracellular immunoflu-
orescence analysis revealed that this complex localizes
to the perinuclear region, likely the endoplasmic reticu-
lum or intermediate compartment (Fig. 5). Replicase
complex formation and ER localization has also been
reported for the EAV replicase (Snijder et al., 1994; van
Dinten et al., 1996). Similarly, one MHV-A59 ORF1a prod-
uct has been localized to the Golgi apparatus by immun-
ofluorescent staining (Bi et al., 1995). It is interesting to
note that although EAV ORF1b products localize to mem-
branes, the only hydrophobic, potentially membrane-
spanning regions of gene 1 are found within ORF1a
surrounding the viral 3C-like nsp4 protease domain
(Snijder et al., 1994). Additionally, EAV ORF1a proteins
have been shown to coimmunoprecipitate with ORF1b-
specific antisera (van Dinten et al., 1996), suggesting
strong protein–protein interactions between the cleaved
gene 1 products in vivo.
For the MHV replicase, the two regions flanking the
3Cpro, termed MP1 and MP2, are likely transmembrane
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domains which may direct the precursor polyprotein to
intracellular membranes. For MHV-A59 it has been
shown that the hydrophobic domains flanking 3Cpro
associate with membrane fractions of in vitro translation
reactions (Pin˜o´n et al., 1997). Even after proteolytic pro-
cessing, these transmembrane domains may anchor
3Cpro and other ORF1a/ORF1b proteins to membranes
by strong protein–protein interactions. The results of
Pin˜o´n et al. (1997) demonstrated that addition of mem-
branes to an in vitro transcription/translation reaction
significantly increased the efficiency of 3Cpro cleavage
from flanking hydrophobic regions. Similarly, we found
that addition of canine microsomal membranes to in vitro
transcription/translation reactions of an MHV-JHM 3Cpro
precursor dramatically enhanced the efficiency of the
processing events, generating a p27 (3Cpro catalytic
core; Fig. 6). These results are consistent with the hy-
pothesis that membrane association of 3Cpro in vivo is
probably necessary for it to adopt a proteolytically effi-
cient conformation and that the regions surrounding this
domain are responsible for mediating its membrane as-
sociation.
Taken together, these data imply that Nidovirus gene 1
cleavage products assemble into a large replication
complex that is anchored to membranes by protein–
protein interactions with the hydrophobic ORF1a prod-
uct(s). Future studies are aimed at determining if altered
proteolytic processing or assembly of the replicase com-
plex affects viral RNA synthesis.
MATERIALS AND METHODS
Virus and cells
Plaque-cloned MHV strains JHM (Makino et al., 1984)
and A59 (Lai and Stohlman, 1981) were used throughout
this study. Gene 1 of both strains has been completely
cloned and sequenced (Lee et al., 1991, as modified by
Bonilla et al., 1994 for MHV-JHM; Bredenbeek et al., 1990,
and Bonilla et al., 1994, for MHV-A59). The viruses were
propagated on DBT cells (Hirano et al., 1974) maintained
in Dulbecco’s modified eagle medium supplemented
with 5% fetal calf serum (FCS), 10% tryptone phosphate
broth, 2% penicillin/streptomycin, and 2% L-glutamine (all
tissue culture reagents were from Gibco-BRL, Gaithers-
berg, MD).
Generation of rabbit antisera to MHV-JHM ORF1a
regions
A panel of antisera directed against specific do-
mains of MHV-JHM ORF1a was generated using the
overall strategy of reverse transcription and polymer-
ase chain reaction (RT-PCR) amplification of a region
of interest, cloning and expression of the region as a
GST-fusion protein, purification of the GST-ORF1a fu-
sion protein, and injection of the purified fusion protein
into rabbits. Briefly, DBT cells were infected with MHV-
JHM at a multiplicity of infection (m.o.i.) of 5. RNA was
isolated from the cells at 12–13 h postinfection (p.i.)
using RNAzol B according to manufacturer’s instruc-
tions (Tel-test, Inc., Friendswood, TX). cDNA was gen-
erated by first denaturing 0.1 mg RNA with 18 mM
methyl mercury hydroxide for 5 min at room tempera-
ture. The RNA was then incubated for 2 h at 42°C in a
reaction mixture containing the following: 0.07 M
b-mercaptoethanol, 0.1 mg random hexamer oligonu-
cleotide primers, 10 mM each deoxyribonucleoside
triphosphate, 85 mM Tris–HCl, pH 8.3, 34 mM KCl, 8.5
mM MgCl2, 40 U of RNAsin and 8 U of avian myelo-
blastosis virus reverse transcriptase (Seikagaku
America, Inc., Rockville, MD). The cDNA synthesis
reaction was terminated by heat inactivation at 95°C
for 3 min, and then quickly cooled on ice.
Regions of interest were amplified from the cDNA
using specific primers (Table 1). Each PCR reaction
contained approximately 30 ng of cDNA, 0.4 mM each
primer, 0.25 mM each dNTP, 1 ml Advantage KlenTaq
Polymerase Mix, and 103 PCR reaction buffer (Clon-
tech, Palo Alto, CA) in a total reaction volume of 50 ml.
Amplification conditions consisted of 35 cycles of:
94°C for 2 s, 50°C for 30 s, and 68°C for 1 min. Each
PCR product was digested with restriction enzymes
and ligated into the XbaI and HindIII sites of the
bacterial expression vector pGEX-KG (kindly provided
by Dr. Steven Broyles, Indiana University). Following
transformation of the ligation reaction into Escherichia
coli DH5 alpha cells, ampicillin-resistant bacteria were
induced for fusion protein production using the
method of Guan and Dixon (1991). Briefly, bacteria
were grown at 30°C in 23 YT containing 50 mg/ml
ampicillin until cultures reached an OD600 of 0.5–0.55.
Fusion proteins were then induced by the addition of
IPTG, as optimized for each transformant: 50 mM IPTG
for 1 h (D5, D12, and D15), 50 mM IPTG for 2 h (D10),
or 100 mM IPTG for 2 h (D3). Cells were harvested by
centrifugation (3000 g). The bacteria from 1 l of culture
was resuspended in 100 ml PBS and lysed by sonica-
tion. Fusion proteins were isolated from the soluble
fraction by affinity chromatography over glutathione–
sepharose bead columns as described by the manu-
facturer (Pharmacia Biotech, Piscataway, NJ). The fu-
sion proteins were eluted by competition with 20 mM
glutathione in 120 mM NaCl and 100 mM Tris–HCl, pH
8.0. The yield per liter of culture varied greatly, ranging
from 400 mg to 7 mg, depending on the apparent
solubility of each fusion protein. Approximate yields of
purified protein were as follows: D3, 7.0 mg/l; D5, 970
mg/l; D10, 800 mg/l; D12, 400 mg/l, and D15, 2.5 mg/l.
Rabbits were injected intramuscularly and subcutane-
ously with 1 ml of 200–500 mg protein emulsified in 1
ml of Freund’s adjuvant (complete adjuvant for first
injection; incomplete for two or three subsequent in-
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jections, each approximately 30 days apart). Immune
sera were collected 10–14 days following each injec-
tion.
Preparation of radiolabeled whole cell lysates
Monolayers of 80–100% confluent DBT cells in 100 mm
petri dishes were infected with MHV-JHM at an m.o.i. of
5–10 plaque-forming units/cell for 1 h, and then incu-
bated at 37°C in supplemented media containing 4
mg/ml Actinomycin D for an additional 4.5 h. At 5.5 h p.i.
media were replaced with MEM lacking methionine for
30 min. Proteins were metabolically radiolabeled with
[35S]methionine (100 mCi/ml; ICN, Costa Mesa, CA) for 90
min, unless indicated otherwise in the text. For direct
labeling experiments, cells were washed following label-
ing with cold PBS on ice and lysed in 300 ml of either
lysis buffer A or B (see below). For pulse–chase experi-
ments, cells in 60-mm dishes were labeled for 30 min,
washed twice with supplemented MEM, and incubated
with media containing a 10-fold excess of methionine (3
mM) and cysteine (4 mM) for the chase periods. At the
times p.i. indicated in the text for each experiment, one
plate of cells was washed with cold PBS on ice and lysed
in 150 ml of lysis buffer A. Lysis buffer A contained 4%
SDS, 3% DTT, 40% glycerol, and 0.0625 M Tris, pH 6.8 (as
previously described, Baker et al., 1989). Lysates pre-
pared in buffer A were passed through a 22-gauge nee-
dle to shear chromosomal DNA and either used directly
or frozen at 280°C. Lysis buffer B contained 100 mM
NaCl, 10 mM Tris–HCl, pH 7.5, 1 mM EDTA, 0.5% NP-40,
0.1 mM PMSF, and 0.3 TIU/ml aprotinin. Lysates prepared
in buffer B were solubilized by pipetting, nuclei pelleted
by centrifugation for 5 min at 8000 rpm, and the post-
nuclear supernatants harvested and either used directly
or frozen at 280°C.
Immunoprecipitation of MHV-JHM ORF1a proteins
Virus-encoded polyproteins expressed during infec-
tion of DBT cells were identified by immunoprecipitation
from whole cell lysates prepared as described above.
Lysates from about 1 3 106 cells were immunoprecipi-
tated with 5–10 ml of antisera in a total volume of 1 ml
RIPA buffer (0.5% Triton X-100, 0.1% SDS, 300 mM NaCl,
50 mM Tris–HCl, pH 7.4, 4 mM EDTA). Antibody–antigen
complexes were precipitated by addition of 40 ml of a 1:1
suspension of protein A–Sepharose CL4B beads (Phar-
macia Biotech, Piscataway, NJ) in RIPA buffer. Antibody–
antigen complexes were washed one time with 1 ml RIPA
buffer, and then incubated 30 min at 37°C or boiled for 3
min in 30 ml of Laemmli 23 sample buffer (Laemmli,
1970). Proteins were electrophoresed on 15% polyacryl-
amide gels containing 0.1% sodium dodecyl sulfate
(SDS–PAGE gels) or 5–15% gradient SDS–PAGE gels, as
indicated in the text. Following electrophoresis, gels
were fixed in 25% methanol and 10% acetic acid, en-
hanced with Entensify A and B (NEN Research Products,
Boston, MA), dried, and exposed to Kodak X-ray film at
280°C.
Molecular mass estimates of MHV-JHM ORF1a
products
For molecular mass determinations, immunoprecipi-
tated products were electrophoresed on 5 and 7.5%
SDS–PAGE gels along with three standards: See Blue,
which contains a 250-kDa protein (Novex, San Diego,
CA), Bench Mark, and a 14C high molecular weight stan-
dard (Gibco BRL, Gaithersburg, MD). Estimates of mo-
lecular mass of ORF1a products were calculated from
regression curves of log molecular weight vs. relative
mobility (Rf) established using the standards.
Immunofluorescence detection of MHV-JHM ORF1a
proteins
Monolayers of 5.0 3 104 DBT cells in eight-well cham-
ber slides were infected with MHV-JHM at an m.o.i. of 10
and incubated at 37°C. At 5.0–5.5 h p.i., the cells were
washed two times with PBS and fixed with 3.7% formal-
dehyde in PBS for 30 min. The fixed cells were washed
three times with PBS containing 10 mM glycine, perme-
abilized with 0.1% Triton X-100 for 10 min, and then
washed three times with PBS containing 10 mM glycine.
The fixed cells were incubated overnight with 1:2000–1:
3500 dilutions of the designated primary rabbit antisera
in PBS, 5% FCS, and 0.3% saponin (ICN, Cleveland, OH)
at 4°C in a moist chamber. Following this incubation,
cells were washed with PBS and 0.03% saponin for 1 h,
and then incubated with FITC-conjugated donkey anti-
rabbit IgG (Jackson ImmunoResearch Laboratories, West
Grove, PA) at a dilution of 1:200 in PBS, 5% FCS, 0.3%
saponin, and 0.001% DAPI (4,96-diamidino-2-phenylin-
dole; Sigma, St. Louis, MO) at 37°C for 1 h. The cells
were then washed with PBS and 0.03% saponin for 1 h
and mounted with 50% glycerol and glass coverslips. The
cells were examined under a fluorescence microscope
(Nikon) and photographed using Fuji (ASA 800) color
print film.
In vitro cloning and expression of the MHV-JHM 3C-
like proteinase domain
The 3C proteinase domain was RT-PCR amplified as
described above using the primers indicated in Table 1.
The forward PCR primer was designed with an ATG start
codon in good Kozak consensus sequence (Kozak, 1989),
and the reverse primer was designed with an in-frame
stop codon. The PCR product was digested with XbaI
and EcoRI and directionally cloned into plasmid pET-11d
(Novagen, Madison, WI) under the control of a T7 pro-
moter and lac operator. This plasmid was designated
pET-3Cpro. To generate the mutant 3Cpro expression
construct, the BamHI–EcoRI fragment of pET-3Cpro was
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replaced with a fragment generated by PCR using prim-
ers B153 and B158 (Table 1), which encodes an arginine
instead of a cysteine at position 3481. The resultant
plasmid was designated pET-mut3Cpro. The catalytic
regions of pET-3Cpro and pET-mut3Cpro were confirmed
by dideoxy sequencing (Sequenase DNA sequencing kit,
Version 2.0; U. S. Biochemicals, Cleveland, OH) using
primer B169 (59-CATACAATGGCAGACCC-39), which
binds nucleotides 10572–10588 of MHV-JHM ORF1a
(numbered according to Lee et al., 1991, as modified by
Bonilla et al., 1994).
Plasmid DNAs were cotranscribed and translated in
rabbit reticulocyte lysates (TNT lysates; Promega Bio-
tech, Madison, WI) according to the manufacturer’s in-
structions. Reactions were performed in a total volume of
12.5 ml using approximately 1 mg of supercoiled plasmid
DNA and 10 mCi of [35S]methionine (ICN Biomed., Costa
Mesa, CA), and incubated at 30°C for 90 min. [35S]Me-
thionine incorporation into the translation products was
quantitated by trichloroacetic acid (TCA) precipitation
(Maniatis et al., 1982). Equal TCA-precipitable counts
(50,000 cpm) of each protein product were mixed with
Laemmli 23 sample buffer, boiled 3 min, analyzed by gel
electrophoresis in 12.5% SDS–PAGE gels, and visualized
by fluorography, as described above.
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